banner about

WHO WE ARE

TIMELY INFORMATION FOR LIFE DECISIONS

 

 

 

 

ABOUT

Today’s doctors, medical and veterinary, face the delicate challenge of diagnosis everyday but the tools available to them are far from perfect. Medical practitioners often have to trade off performance with convenience.

 

Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Biomedical Pte. Ltd. develops, manufactures, and commercializes an accurate, rapid and affordable molecular diagnostic platform at the Point-Of-Care: the QubeMDx.

 

Conscious of the necessity to simplify processes and accelerate diagnostics turnaround times at lower costs while ensuring the best accuracy, we provide solutions for diagnosis in the areas of Human Health, and Animal Care.

 

The diagnostic companies have a moral responsibility and duty to the doctors and patients to provide better tools, and we envision that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management.

 

 

 

 

HISTORY

2011

CREDO BIOMEDICAL

FOUNDED IN SINGAPORE

2014

ANIMAL CARE

COOPERATION WITH NTU AND TAIWAN VETERINARY ASSOCIATION

2015

ANIMAL CARE

CONTRACT WITH COMPANY K (JAPAN) FOR R&D AND DISTRIBUTION

2017

HUMAN HEALTH

FIRST CLINICAL STUDIES IN ASIA

2019

AN EXTENSIVE MENU AVAILABLE

 

 

 

CONTACT

We at Credo pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.